This document is an excerpt from the EUR-Lex website
Document 62017TN0165
Case T-165/17: Action brought on 10 March 2017 — Emcur v EUIPO — Emcure Pharmaceuticals (EMCURE)
Case T-165/17: Action brought on 10 March 2017 — Emcur v EUIPO — Emcure Pharmaceuticals (EMCURE)
Case T-165/17: Action brought on 10 March 2017 — Emcur v EUIPO — Emcure Pharmaceuticals (EMCURE)
OJ C 129, 24.4.2017, p. 39–39
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
24.4.2017 |
EN |
Official Journal of the European Union |
C 129/39 |
Action brought on 10 March 2017 — Emcur v EUIPO — Emcure Pharmaceuticals (EMCURE)
(Case T-165/17)
(2017/C 129/59)
Language in which the application was lodged: English
Parties
Applicant: Emcur Gesundheitsmittel aus Bad Ems GmbH (Bad Ems, Germany) (represented by: K. Bröcker, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Emcure Pharmaceuticals Ltd (Bhosari, India)
Details of the proceedings before EUIPO
Applicant: Other party to the proceedings before the Board of Appeal
Trade mark at issue: EU word mark ‘EMCURE’ — Application for registration No 12 269 049
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 13 December 2016 in Case R 790/2016-2
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009. |